BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7808072)

  • 1. [Fungemia caused by Candida krusei in a female patient with AIDS].
    Laguna F; Martínez-Suárez JV; Adrados M
    Med Clin (Barc); 1994 Nov; 103(17):678. PubMed ID: 7808072
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluconazole resistance of Candida krusei.
    Manso E; Montillo M; Discepoli G; Leoni P
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
    Cancelas JA; Lopez J; Cabezudo E; Navas E; Garcia Laraña J; Jimenez Mena M; Diz P; Perez de Oteyza J; Villalon L; Sanchez-Sousa A
    Bone Marrow Transplant; 1994 Mar; 13(3):333-4. PubMed ID: 8199575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance of Candida sp. to fluconazole in AIDS patients].
    Polanco AM; Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):462-4. PubMed ID: 8260524
    [No Abstract]   [Full Text] [Related]  

  • 6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A; Brown P; Vazquez JA
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.
    Dewsnup DH; Stevens DA
    J Med Vet Mycol; 1994; 32(5):389-93. PubMed ID: 7844704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
    Solomkin JS
    New Horiz; 1993 May; 1(2):202-13. PubMed ID: 7922404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimycotic agents selectively damages the fungus membrane. AIDS patients--cryptococcosis--oropharyngeal candidiasis].
    Meissner GF
    Fortschr Med; 1991 Apr; 109(13):84. PubMed ID: 2066048
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
    Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
    [No Abstract]   [Full Text] [Related]  

  • 13. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal Candida dubliniensis septicemia in a patient with AIDS.
    Chan-Tack KM
    Clin Infect Dis; 2005 Apr; 40(8):1209-10. PubMed ID: 15791525
    [No Abstract]   [Full Text] [Related]  

  • 16. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
    Coppola S; Angarano G; Montagna MT; Congedo P; Monno L; Bellisario A; Pastore G
    Eur J Epidemiol; 1995 Apr; 11(2):243-4. PubMed ID: 7672085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
    Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
    Thomas F; Mebtouche B; Clavier H; Kalfon P
    Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole resistance of Candida glabrata in a case of recurrent fungemia.
    Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
    J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.